Mechanism of gram-positive shock: Identification of peptidoglycan and lipoteichoic acid moieties essential in the induction of nitric oxide synthase, shock, and multiple organ failure

Journal of Experimental Medicine

Volumn 188, Issue 2, 1998, Pages 305-315

  Kengatharan, Ken M ^a   De Kimpe, Sjef ^b   Robson, Caroline ^a   Foster, Simon J ^c   Thiemermann, Christoph ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b UTRECHT UNIVERSITY   (Netherlands)

^c UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

Gram positive shock; Lipoteichoic acid; Nitric oxide; Peptidoglycan

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; LIPOTEICHOIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ANIMAL CELL; ANTIGENICITY; ARTICLE; BACILLUS SUBTILIS; ENZYME INDUCTION; IMMUNOPATHOGENESIS; MACROPHAGE; MOUSE; MULTIPLE ORGAN FAILURE; NONHUMAN; OXIDATION REDUCTION REACTION; PRIORITY JOURNAL; RAT; SEPTIC SHOCK; STAPHYLOCOCCUS AUREUS;

ANIMALS; BACILLUS SUBTILIS; CELL LINE; ENZYME INDUCTION; LIPOPOLYSACCHARIDES; MACROPHAGES; MICE; MULTIPLE ORGAN FAILURE; NITRIC OXIDE SYNTHASE; PEPTIDE FRAGMENTS; PEPTIDOGLYCAN; RATS; SHOCK, SEPTIC; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; TEICHOIC ACIDS;

EID: 0031821974     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.188.2.305     Document Type: Article

References (48)

1. Bone, R.C. 1994. Gram-positive organisms and sepsis. Arch. Intern. Med. 154:26-34.
2. Nogare, A.R. 1991. Southwestern Internal Medicine Conference: septic shock. Am. J. Med. Sci. 302:50-65.
3. Natanson, C., R.L. Danner, R.J. Elin, J.M. Hosseini, K.W. Peart, S.M. Banks, T.J. Macvittie, R.I. Walker, and J.E. Parrillo. 1989. Role of endotoxemia in cardiovascular dysfunction and mortality. Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J. Clin. Invest. 83:243-251.
4. Wakabayashi, G., J.A. Gelfand, W.K. Jung, R.J. Connolly, J.F. Burke, and C.A. Dinarello. 1991. Staphylococcus epidermidis induces complement activation, tumor necrosis factor and interleukin-1, a shock-like state and tissue injury in rabbits without endotoxemia. Comparison to Escherichia coli. J. Clin. Invest. 87:1925-1935.
5. Mattsson, E., L. Verhage, J. Rollof, A. Fleer, J. Verhoef, and H. Vandijk. 1993. Peptidoglycan and teichoic acid from Staphylococcus epidermidis stimulate human monocytes to release tumor necrosis factor-α, interleukin-1β and interleukin-6. FEMS Immunol. Med. Microbiol. 7:281-287.
6. Heumann, D., C. Barras, A. Severin, M.P. Glauser, and A. Tomasz. 1994. Gram-positive cell walls stimulate synthesis of tumor necrosis factor-α and interleukin-6 by human monocytes. Infect. Immunol. 62:2715-2721.
7. Bhakdi, S., M. Muhly, S. Korom, and F. Hugo. 1989. Release of interleukin-1β associated with potent cytocidal action of staphylococcal alpha-toxin on human monocytes. Infect. Immun. 57:3512-3519.
8. Bhakdi, S., T. Klonisch, P. Nuber, and W. Fischer. 1991. Stimulation of monokine production by lipoteichoic acids. Infect. Immun. 59:4614-4620.
9. Moncada, S., and A. Higgs. 1993. The L-arginine-nitric oxide pathway. N. Engl. J. Med. 329:2002-2012.
10. Moncada, S., and A. Higgs. 1995. Molecular mechanisms and therapeutic strategies related to nitric oxide. FASEB (Fed. Am. Soc. Exp. Biol.) J. 9:1319-1330.
11. Thiemermann, C. 1994. The role of the L-arginine: nitric oxide pathway in circulatory shock. Adv. Pharmacol. 28:45-79.
12. Thiemermann, C. 1998. The use of selective inhibitors of inducible nitric oxide synthase. Sepsis. 1:123-129.
13. Fischer, W. 1988. Physiology of lipoteichoic acids in bacteria. Adv. Microb. Physiol. 29:233-302.
14. Shaw, N. 1974. Lipid composition as a guide to the classification of bacteria. Adv. Appl. Microbiol. 17:63-108.
15. Auguet, M., M.-O. Lonchampt, S. Delaflotte, J. Goulin-Schulz, P.E. Chabrier, and P. Braquet. 1992. Induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in vascular smooth muscle cells. FEBS (Fed. Eur. Biol. Soc.) Lett. 297:183-185.
16. De Kimpe, S.J., M.L. Hunter, C.E. Bryant, C. Thiemermann, and J.R. Vane. 1995. Delayed circulatory failure due to the induction of nitric oxide synthase by lipoteichoic acid from Staphylococcus aureus in anaesthetised rats. Br. J. Pharmacol. 114:1317-1323.
17. Kengatharan, M., S.J. De Kimpe, and C. Thiemermann. 1996. Analysis of the signal transduction in the induction of nitric oxide synthase by lipoteichoic acid in macrophages. Br. J. Pharmacol. 117:1163-1170.
18. De Kimpe, S.J., M. Kengatharan, C. Thiemermann, and J.R. Vane. 1995. The cell wall components peptidoglycan and lipoteichoic acid from Staphylococcus aureus act in synergy to cause shock and multiple organ failure. Proc. Natl. Acad. Sci. USA. 92:10359-10363.
19. Kengatharan, M.K., S.J. De Kimpe, and C. Thiemermann. 1996. Role of nitric oxide synthase in the circulatory failure and organ injury in a rodent model of gram-positive shock. Br. J. Pharmacol. 119:1411-1421.
20. Foster, S.J. 1992. Analysis of the autolysins of Bacillus subtilis 168 during vegetative growth and differentiation by using renaturing polyacrylamide gel electrophoresis. J. Bacteriol. 174:464-470.
21. Timmerman, C.P., E. Mattsson, L. Martinez-Martinez, L. De Graaf, J.A.G. Vanstrijp, H.A. Verbrugh, J. Verhoef, and A. Fleer. 1993. Induction of release of tumor necrosis factor from human monocytes by staphylococci and staphylococcal peptidoglycans. Infect. Immun. 61:4167-4172.
22. Kusunoki, T., E. Hailman, T.S.C. Juan, H.S. Lichenstein, and S.D. Wright. 1995. Molecules from Staphylococcus aureus that bind CD14 and stimulate innate immune responses. J. Exp. Med. 182:1673-1682.
23. G-methyl-arginine. Biochem. Biophys. Res. Commun. 170:96-103.
24. Bryant, C.E., A. Tomlinson, J.A. Mitchell, C. Thiemermann, and D.A. Willoughby. 1995. Nitric oxide synthase in the rat fallopian tube is regulated during the estrous cycle. J. Endocrinol. 146:149-157.
25. Deitch, E.A. 1992. Multiple organ failure. Pathophysiology and potential future therapy. Ann. Surg. 216:117-134.
26. Baue, A.E. 1993. The multiple organ or system failure syndrome. In Pathophysiology of Shock, Sepsis and Organ Failure. G. Schlag and H. Redl, editors. Springer-Verlag, Berlin. 1004-1018.
27. Wallenstein, S., L.C. Zucker, and J.L. Fleiss. 1980. Some statistical methods useful in circulation research. Circ. Res. 47:1-9.
28. Cunha, F.Q., D.W. Moss, L.M.C.C. Leal, S. Moncada, and F.Y. Liew. 1993. Induction of macrophage parasiticidal activity by Staphylococcus aureus and exotoxins through the nitric oxide synthesis pathway. Immunology. 78:563-567.
29. Keller, R., W. Fischer, R. Keist, and S. Bassetti. 1992. Macrophage response to bacteria: induction of marked secretory and cellular activities by lipoteichoic acids. Infect. Immun. 60: 3664-3672.
30. Kawata, S., T. Takemura, K. Yokogawa, and S. Kotani. 1984. Studies on lytic enzymes toward cariogenic streptococci .9. isolation of bacteriolytic endopeptidase from a strain of cytophaga and its application to preparation of hydrosoluble polysaccharide peptide from Staphylococcus epidermidis peptidoglycan. Agric. Biol. Cem. 48:2253-2263.
31. Wadstrom, T., and O. Vesterberg. 1971. Studies on endo-β-acetylglucosaminidase, staphylolytic peptidase, and N-acetylmuramyl-L-alanine amidase in lysostaphin and from Staphylococcus aureus. Acta Pathol. Microbiol. Scand. [B] Microbiol. Immunol. 79:248-264.
32. Chedid, L., and E. Lederer. 1978. Past, present and future of the synthetic immunoadjuvant MDP and its analogs. Biochem. Pharmacol. 27:2183-2186.
33. Seidl, P.H., and K.H. Schleifer. 1986. Structure and immunochemistry of peptidoglycan. In Biological Properties of Peptidoglycans. P.H. Seidl and K.H. Schleifer, editors. Walter de Gruyter & Co., New York. 1-20.
34. Pristovsek, P., J. Kidric, and D. Hadzi. 1995. Bioactive conformations of small peptides: a method for selection of candidates based on conformations of active and inactive analogues and its application to muramyl dipeptide. J. Chem. Inf. Comput. Sci. 35:633-639.
35. Fischer, W. 1996. Molecular analysis of lipid macroamphiphiles by hydrophobic interaction chromatography. J. Microbiol. Methods. 25:129-144.
36. Takada, H., Y. Kawabata, R. Arakaki, S. Kusumoto, K. Fukase, Y. Suda, T. Yoshimura, S. Kokeguchi, K. Kato, T. Komuro, et al. 1995. Molecular and structural requirements of a lipoteichoic acid from Enterococcus hirae ATCC 9790 for cytokine-inducing, antitumor, and antigenic activities. Infect. Immun. 63:57-65.
37. Himanen, J.P., L. Pyhala, R.M. Olander, O. Merimskaya, T. Kuzina, O. Lysyuk, A. Pronin, A. Sanin, I.M. Helander, and M. Sarvas. 1993. Biological activities of lipoteichoic acid and peptidoglytan-teichoic acid of Bacillus subtilis 168 (Marburg). J. Gen. Microbiol. 139:2659-2665.
38. Himanen, J.K. M. Sarvas, and I.M. Helander. 1993. Assessment of nonprotein impurities in potential vaccine proteins produced by Bacillus subtilis. Vaccine. 11:970-973.
39. Card, G.L, R.R. Jasuja, and G.L. Gustafson. 1994. Activation of arachidonic acid metabolism in mouse macrophages by bacterial amphiphiles. J. Leukocyte Biol. 56:723-728.
40. Fischer, W., and P. Rosel. 1980. The alanine ester substitution of lipoteichoic acid (LTA) in Staphylococcus aureus. FEBS (Fed. Eur. Biol. Soc.) Lett. 119:224-226.
41. Fischer, W., T. Mannsfeld, G. Hagen, and G. Fischer. 1990. On the basic structure of poly(glycerophosphate) lipoteichoic acids. Biochem. Cell Biol. 68:33-43.
42. Wicken, A.J., and K.W. Knox. 1975. Lipoteichoic acids: a new class of bacterial antigen. Science. 187:1161-1167.
43. Schleifer, K.H., and O. Kandler. 1972. Peptidoglycan types of bacterial cell walls and their taxonomic implications. Bacteriol. Rev. 36:407-477.
44. Glauner, B. 1988. Separation and quantification of muropeptides with high-performance liquid chromatography. Anal. Biochem. 172:451-464.
45. Dziarski, R. 1991. Demonstration of peptidoglycan binding sites on lymphocytes and macrophages by photoaffinity cross-linking. J. Biol. Chem. 266:4713-4718.
46. Rabini, R.L., M.M. Bieber, and N.N.H. Teng. 1993. Lipopolysaccharide and peptidoglycan share binding sites on human peripheral blood monocytes. J. Infect. Dis. 168:135-142.
47. Ginsburg, I. 1988. The biochemistry of bacteriolysis: paradoxes, facts and myths. Microbiol. Sci. 5:137-142.
48. Vermeulen, M.W., and G.R. Gray. 1984. Processing of Bacillus subtilis peptidoglycan by a mouse macrophage cell line. Infect. Immun. 46:476-483.